From: Evaluation of suspected malignant hyperthermia events during anesthesia
No | IVCT | Trigger agents | Masseterspasm | Dantrolene application | Cardiac arrhythmia | Max. end-tidal CO2[mmHg] | Max. temperature | Max. Creatine kinase [U/L] |
---|---|---|---|---|---|---|---|---|
1 | MHS | Isoflurane + SCh | Unknown | 1 × 200 mg | Sinus tachycardia | 48 mmHg | 38.8°C | 10.514 |
2 | MHS | Isoflurane + SCh | Yes | 1 × 240 mg | Tachyarrhythmia | 54 mmHg | 36.1°C | > 10.000 |
3 | MHS | Sevoflurane + SCh | Yes | No | Sinus tachycardia | Unknown | Unknown | 51.557 |
4 | MHS | Sevoflurane + SCh | Unknown | 2 × 200 mg | Sinus tachycardia | 62 mmHg | Unknown | 23.700 |
5 | MHS | Desflurane + SCh | Unknown | 1 × 220 mg | Tachyarrhythmia | 56 mmHg | 37.6°C | ≈ 80.000 |
6 | MHS | Sevoflurane | No | 1 × 200 mg | No | 85 mmHg | 37.5°C | 38.762 |
7 | MHS | Isoflurane + SCh | Unknown | No | Unknown | Unknown | Unknown | 16.412 |
8 | MHEh | SCh | Yes | 1 × 200 mg | Unknown | 39 mmHg | Unknown | 119.150 |
9 | MHEh | SCh | Yes | Unknown | No | 36 mmHg | Unknown | 162 |
10 | MHEh | SCh | Yes | No | Unknown | Unknown | Unknown | 2.234 |
11 | MHEh | Halothane + SCh | Yes | Unknown | Tachyarrhythmia | Unknown | Unknown | Low |
12 | MHN | SCh | Yes | No | Tachyarrhythmia | Unknown | Unknown | 132 |
13 | MHN | Isoflurane | Yes | No | Unknown | 54 mmHg | Unknown | 4.100 |
14 | MHN | SCh | Yes | No | Unknown | Unknown | Unknown | 24.732 |
15 | MHN | Desflurane | No | 1 × 180 mg | Tachyarrhythmia | 72 mmHg | Unknown | Unknown |
16 | MHN | SCh | Yes | No | Unknown | Unknown | Unknown | Unknown |
17 | MHN | Desflurane | No | No | Unknown | Unknown | 38,5°C | Unknown |
18 | MHN | Isoflurane + SCh | Yes | No | Unknown | 41 mmHg | Unknown | 5.174 |
19 | MHN | Enflurane + SCh | Yes | No | Unknown | 75 mmHg | Unknown | 4.820 |